The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State

International Review of Neurobiology

Volumn 63, Issue , 2005, Pages 101-154

  Melis, Miriam ^b   Spiga, Saturnino ^b   Diana, Marco ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ADDICTION; ANIMAL; BRAIN; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; DOPAMINE; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 17844390131     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(05)63005-X     Document Type: Article

References (459)

1. Ackerman J.M., and White F.J. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. Eur. J. Pharmacol. 21 (1992) 171-173
2. Acquas E., Carboni E., and Di Chiara G. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol. 25 (1991) 133-134
3. Aghajanian G.K., and Bunney B.S. Dopamine "autoreceptors": Pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch. Pharmacol. 14 (1977) 1-7
4. Agnati L.F., Bjelke B., and Fuxe K. Volume versus wiring transmission in the brain: A new theoretical frame for neuropsychopharmacology. Med. Res. Rev. 15 (1995) 33-45
5. Alheid G.F., Beltramino C.A., De Olmos J.S., Forbes M.S., Swanson D.J., and Heimer L. The neuronal organization of the supracapsular part of the stria terminalis in the rat: The dorsal component of the extended amygdala. Neuroscience 84 (1998) 967-996
6. Altman J. A biological view of drug abuse. Mol. Med. Today 2 (1996) 237-241
7. Amini B., Clark Jr. J.W., and Canavier C.C. Calcium dynamics underlying pacemaker-like and burst firing oscillations in midbrain dopaminergic neurons: A computational study. J. Neurophysiol. 82 (1999) 2249-2261
8. Anden N.E., Dahlstrom A., Fuxe K., and Larsson K. Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol. Toxicol. (Copenh.) 24 (1966) 263-274
9. Ang E., Chen J., Zagouras P., Magna H., Holland J., Schaeffer E., and Nestler E.J. Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J. Neurochem. 79 (2001) 221-224
10. Asher O., Cunningham T.D., Yao L., Gordon A.S., and Diamond I. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J. Pharmacol. Exp. Ther. 301 (2002) 66-70
11. Ator N.A., and Griffiths R.R. Nicotine self-administration in baboons. Pharmacol. Biochem. Behav. 19 (1983) 993-1003
12. Ator N.A., and Griffiths R.R. Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend. 5 3 Suppl (2003) S55-S72
13. Bailey C.P., Manley S.J., Watson W.P., Wonnacott S., Molleman A., and Little H.J. Chronic ethanol administration alters activity in ventral tegmental area neurons after cessation of withdrawal hyperexcitability. Brain Res. 24 1-2 (1998) 144-152
14. Bailey C.P., O'Callaghan M.J., Croft A.P., Manley S.J., and Little H.J. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology 41 (2001) 989-999
15. Balfour M.E., Yu L., and Coolen L.M. Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 29 (2004) 718-730
16. Balster R.L., Kilbey M.M., and Ellinwood Jr. E.H. Methamphetamine self-administration in the cat. Psychopharmacologia 15 (1976) 229-233
17. Bassareo V., Tanda G., and Di Chiara G. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berlin) 122 (1995) 202-205
18. Bayer V.E., and Pickel V.M. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: Relationship between immunolabeling density and neuronal associations. J. Neurosci. 10 (1990) 2996-3013
19. Bean A.J., and Roth R.H. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: Effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci. 11 (1991) 2694-2702
20. Bechara A., Nader K., and van der Kooy D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol. Biochem. Behav. 59 (1998) 1-17
21. Bedford J.A., Borne R.F., and Wilson M.C. Comparative behavioral profile of cocaine and norcocaine in rats and monkeys. Pharmacol. Biochem. Behav. 13 (1980) 69-75
22. Beitner-Johnson D., Guitart X., and Nestler E.J. Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12 (1992) 2165-2176
23. Beitner-Johnson D., and Nestler E.J. Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system. Neuroreport 5 (1993) 57-60 Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Washington, DC, ed. 4, revised version, 2000)
24. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
25. Bespalov A., Lebedev A., Panchenko G., and Zvartau E. Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur. Neuropsychopharmacol. 9 (1999) 377-383
26. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., and Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 15 6826 (2001) 376-380
27. Bjorklund A., and Lindvall O. Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals. Brain Res. 17 (1975) 531-537
28. Blakesley B.C., Dinneen L.C., Elliott R.D., and Francis D.L. Intravenous self-administration of heroin in the rat: Experimental technique and computer analysis. Br. J. Pharmacol. 45 (1972) 181-182
29. Blanpied T.A., and Ehlers M.D. Microanatomy of dendritic spines: Emerging principles of synaptic pathology in psychiatric and neurological disease. Biol. Psychiatry 15 (2004) 1121-1127
30. Bohn L.M., Gainetdinov R.R., Lin F.T., Lefkowitz R.J., and Caron M.G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 7 (2000) 720-723
31. Boileau I., Assaad J.M., Pihl R.O., Benkelfat C., Leyton M., Diksic M., Tremblay R.E., and Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 15 (2003) 226-231
32. Bonci A., and Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16 (1996) 631-639
33. Bonci A., and Williams J.T. Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 15 (1997) 796-803
34. Bozarth M.A. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res. 23 (1987) 77-84
35. Bozarth M.A., and Wise R.A. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 2 (1981) 551-555
36. Bradberry C.W. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J. Neurosci. 15 (2000) 7109-7115
37. Bradberry C.W. Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys: Comparison with cocaine across individuals. Psychopharmacology (Berlin) 165 (2002) 67-76
38. Bradberry C.W., and Roth R.H. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett. 14 (1989) 97-102
39. Bradberry C.W., Barrett-Larimore R.L., Jatlow P., and Rubino S.R. Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys. J. Neurosci. 15 (2000) 3874-3883
40. Braida D., Pozzi M., Cavallini R., and Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system. Neuroscience 104 (2001) 923-926
41. Britten R.J. Divergence between samples of chimpanzee and human DNA sequences is 5%, counting indels. Proc. Natl. Acad. Sci. USA 15 (2002) 13633-13635
42. Brodie M.S. Increased ethanol excitation of dopaminergic neurons of the ventral tegmental area after chronic ethanol treatment. Alcohol Clin. Exp. Res. 26 (2002) 1024-1030
43. Brodie M.S., and Appel S.B. The effects of ethanol on dopaminergic neurons of the ventral tegmental area studied with intracellular recording in brain slices. Alcohol Clin. Exp. Res. 22 (1998) 236-244
44. Brodie M.S., and Dunwiddie T.V. Cocaine effects in the ventral tegmental area: Evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 342 (1990) 660-665
45. Brodie M.S., Shefner S.A., and Dunwiddie T.V. Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res. 29 (1990) 65-69
46. Brodie M.S., McElvain M.A., Bunney E.B., and Appel S.B. Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons. J. Pharmacol. Exp. Ther. 290 (1999) 325-333
47. Brown R.W., and Kolb B. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res. 27 1-2 (2001) 94-100
48. Bunney B.S., Walters J.R., Roth R.H., and Aghajanian G.K. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185 (1973) 560-571
49. Bunney E.B., Appel S.B., and Brodie M.S. Cocaine potentiates ethanol-induced excitation of dopaminergic reward neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 293 (2000) 383-389
50. Calabresi P., Lacey M.G., and North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol. 98 (1989) 135-140
51. Cameron D.L., and Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14 11 Pt 1 (1994) 6763-6767
52. Cameron D.L., Wessendorf M.W., and Williams J.T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77 (1997) 155-166
53. Carboni E., Imperato A., Perezzani L., and Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 (1989) 653-661
54. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B., and Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J. Neurosci. 1 RC141 (2001) 1-4
55. Cardinal R.N., and Everitt B.J. Neural and psychological mechanisms underlying appetitive learning: Links to drug addiction. Curr. Opin. Neurobiol. 14 (2004) 156-162
56. Carlezon Jr. W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 18 5397 (1998) 2272-2275
57. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 15 (2000) 3864-3873
58. Carroll M.E., France C.P., and Meisch R.A. Food deprivation increases oral and intravenous drug intake in rats. Science 20 4403 (1979) 319-321
59. Charara A., Smith Y., and Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leukoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J. Comp. Neurol. 8 (1996) 254-266
60. Charlety P.J., Grenhoff J., Chergui K., De la Chapelle B., Buda M., Svensson T.H., and Chouvet G. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiol. Scand. 142 (1991) 105-112
61. Cheer J.F., Kendall D.A., Mason R., and Marsden C.A. Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44 (2003) 633-641
62. Chen B.T., and Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J. Neurochem. 81 (2002) 158-169
63. Chen J., Nye H.E., Kelz M.B., Hiroi N., Nakabeppu Y., Hope B.T., and Nestler E.J. Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48 (1995) 880-889
64. Chergui K., Charlety P.J., Akaoka H., Saunier C.F., Brunet J.L., Buda M., Svensson T.H., and Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 1 (1993) 137-144
65. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F., and Conquet F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4 (2001) 873-874
66. Chiodo L.A., Antelman S.M., Caggiula A.R., and Lineberry C.G. Sensory stimuli alter the discharge rate of dopamine (DA) neurons: Evidence for two functional types of DA cells in the substantia nigra. Brain Res. 12 (1980) 544-549
67. Chiodo L.A., Bannon M.J., Grace A.A., Roth R.H., and Bunney B.S. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12 (1984) 1-16
68. Christie M.J., Bridge S., James L.B., and Beart P.M. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res. 29 (1985) 169-172
69. Churchill L., Dilts R.P., and Kalivas P.W. Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem. Res. 17 (1992) 101-106
70. Clarke P.B., and Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 2 (1985) 355-358
71. Comery T.A., Stamoudis C.X., Irwin S.A., and Greenough W.T. Increased density of multiple-head dendritic spines on medium-sized spiny neurons of the striatum in rats reared in a complex environment. Neurobiol. Learn. Mem. 66 (1996) 93-96
72. Conneally P.M., and Sparkes R.S. Molecular genetics of alcoholism and other addiction{plus 45 degree rule}compulsive disorders. General discussion. Alcohol 16 (1998) 85-91
73. Corbett D., and Wise R.A. Intracranial self-stimulation in relation to the ascending noradrenergic fiber systems of the pontine tegmentum and caudal midbrain: A moveable electrode mapping study. Brain Res. 30 (1979) 423-436
74. Corbett D., and Wise R.A. Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: A moveable electrode mapping study. Brain Res. 3 (1980) 1-15
75. Cortes R., and Palacios J.M. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res. 8 (1986) 227-238
76. Cox P.R., Fowler V., Xu B., Sweatt J.D., Paylor R., and Zoghbi H.Y. Mice lacking Tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol. Cell Neurosci. 23 (2003) 1-12
77. Criswell H.E., and Ridings A. Intravenous self-administration of morphine by naive mice. Pharmacol. Biochem. Behav. 18 (1983) 467-470
78. Cryan J.F., Hoyer D., and Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 1 (2003) 49-58
79. Cryan J.F., Bruijnzeel A.W., Skjei K.L., and Markou A. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berlin) 168 (2003) 347-358
80. Daglish M.R., and Nutt D.J. Brain imaging studies in human addicts. Eur. Neuropsychopharmacol. 13 (2003) 453-458
81. Dahlstrom A., and Fuxe K. Localization of monoamines in the lower brain stem. Experientia 15 (1964) 398-399
82. Davis W.M., and Nichols J.R. A technique for self-injection of drugs in the study of reinforcement. J. Exp. Anal. Behav. 6 (1963) 233-235
83. Daw N.W., Stein P.S., and Fox K. The role of NMDA receptors in information processing. Annu. Rev. Neurosci. 16 (1993) 207-222
84. Deneau G.A., and Inoki R. Nicotine self-administration in monkeys. Ann. NY Acad. Sci. 142 (1967) 277-279
85. Deneau G., Yanagita T., and Seevers M.H. Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16 (1969) 30-48
86. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 13 5686 (2004) 1014-1017
87. De Wit H., and Wise R.A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can. J. Psychol. 31 (1977) 195-203
88. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 30 1-3 (1999) 13-30
89. Di Chiara G. Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behav. Brain Res. 2 1-2 (2002) 75-114
90. Di Chiara G., and Imperato A. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 10 (1985) 131-132
91. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85 (1988) 5274-5278
92. Di Chiara G., Loddo P., and Tanda G. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: Implications for the psychobiology of depression. Biol. Psychiatry 15 (1999) 1624-1633
93. Di Mascio M., Di Giovanni G., Di Matteo V., Prisco S., and Esposito E. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Brain Res. Bull. 46 (1998) 547-554
94. Diana M. Dopaminergic neurotransmission and drug withdrawal: Relevance to drug craving. In: Ohye C., Kimura M., and McKenzie J. (Eds). "Advances in Behavioral Biology". The Basal Ganglia V vol. 47 (1996), Plenum Press, New York
95. Diana M. Drugs of abuse and dopamine cell activity. Adv. Pharmacol. 42 (1998) 998-1001
96. Diana M., and Tepper J.M. Electrophysiological pharmacology of mesencephalic dopaminergic neurons. In: Di Chiara G. (Ed). "Handbook of Experimental Pharmacology" 154{plus 45 degree rule}II (2002), Springer-Verlag, Berlin
97. Diana M., Gessa G.L., and Rossetti Z.L. Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. Alcohol Alcohol 27 (1992) 329-333
98. Diana M., Pistis M., Muntoni A., Rossetti Z.L., and Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. Eur. J. Pharmacol. 20 2-3 (1992) 403-404
99. Diana M., Rossetti Z.L., and Gessa G. Rewarding and aversive effects of ethanol: Interplay of GABA, glutamate and dopamine. Alcohol Alcohol Suppl. 2 (1993) 315-319
100. Diana M., Pistis M., Carboni S., Gessa G.L., and Rossetti Z.L. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: Electrophysiological and biochemical evidence. Proc. Natl. Acad. Sci. USA 1 (1993) 7966-7969
101. Diana M., Pistis M., Muntoni A., and Gessa G.L. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272 (1995) 781-785
102. Diana M., Pistis M., Muntoni A.L., and Gessa G.L. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Res. 5 1-2 (1995) 29-34
103. Diana M., Pistis M., Muntoni A., and Gessa G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: Evidence of protracted abstinence. Neuroscience 71 (1996) 411-415
104. Diana M., Melis M., and Gessa G.L. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur. J. Neurosci. 10 (1998) 2825-2830
105. Diana M., Melis M., Muntoni A.L., and Gessa G.L. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc. Natl. Acad. Sci. USA 18 (1998) 10269-10273
106. Diana M., Muntoni A.L., Pistis M., Melis M., and Gessa G.L. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur. J. Neurosci. 11 (1999) 1037-1041
107. Diana M., Brodie M., Muntoni A., Puddu M.C., Pillolla G., Steffensen S., Spiga S., and Little H.J. Enduring effects of chronic ethanol in the CNS: Basis for alcoholism. Alcohol Clin. Exp. Res. 27 (2003) 354-361
108. Diana M., Spiga S., Puddu M.C., Fradelloni A., and Serra G.P. Morphine withdrawal-induced spine density decrease in the nucleus accumbens: Selective localization in secondary dendrites of medium spiny neurons. 2003 Abstract Viewer{plus 45 degree rule}Itinerary Planner (2003), Society for Neuroscience, Washington, DC Program no. 645.11.
109. El-Husseini A.E., Schnell E., Chetkovich D.M., Nicoll R.A., and Bredt D.S. PSD-95 involvement in maturation of excitatory synapses. Science 17 5495 (2000) 1364-1368
110. Einhorn L.C., Johansen P.A., and White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area. J. Neurosci. 8 (1988) 100-112
111. Epping-Jordan M.P., Watkins S.S., Koob G.F., and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 7 6680 (1998) 76-79
112. Erhardt S., Mathe J.M., Chergui K., Engberg G., and Svensson T.H. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 173-180
113. Evans S.M., and Levin F.R. Response to alcohol in females with a paternal history of alcoholism. Psychopharmacology (Berlin) 169 (2003) 10-20
114. Fadda F., and Rossetti Z.L. Chronic ethanol consumption: From neuroadaptation to neurodegeneration. Prog. Neurobiol. 56 4 (1998) 385-431
115. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., and Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 24 1-2 (1992) 235-243
116. Fibiger H.C. Drugs and reinforcement mechanisms: A critical review of the catecholamine theory. Annu. Rev. Pharmacol. Toxicol. 18 (1978) 37-56
117. Fibiger H.C., Carter D.A., and Phillips A.G. Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: Evidence for mediation by motor deficits rather than by reduced reward. Psychopharmacology (Berlin) 5 (1976) 21-27
118. Foddai M., Dosia G., Spiga S., and Diana M. Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology 29 (2004) 530-536
119. Fouriezos G., Hansson P., and Wise R.A. Neuroleptic-induced attenuation of brain stimulation reward in rats. J. Comp. Physiol. Psychol. 92 (1978) 661-671
120. Fowler J.S., Volkow N.D., Ding Y.S., Wang G.J., Dewey S., Fischman M.W., Foltin R., and Hitzemann R. Positron emission tomography studies of dopamine-enhancing drugs. J. Clin. Pharmacol. Suppl (1999) 13S-16S
121. French E.D. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett. 2 (1997) 159-162
122. French E.D., Dillon K., and Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 10 (1997) 649-652
123. Freund T.F., Powell J.F., and Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13 (1984) 1189-1215
124. Funada M., Suzuki T., Narita M., Misawa M., and Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32 (1993) 1315-1323
125. Gao W.Y., Lee T.H., King G.R., and Ellinwood E.H. Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. Neuropsychopharmacology 18 (1998) 222-232
126. Gardner E.L. What we have learned about addiction from animal models of drug self-administration. Am. J. Addict. Fall 9 (2000) 285-313
127. Gardner E.L., Paredes W., Smith D., Donner A., Milling C., Cohen D., and Morrison D. Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berlin) 96 (1988) 142-144
128. Gardner E.L., and Vorel S.R. Cannabinoid transmission and reward-related events. Neurobiol. Dis. 5 6 Pt B (1998) 502-533
129. Gariano R.F., Sawyer S.F., Tepper J.M., Young S.J., and Groves P.M. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation. Brain Res. Bull. 22 (1989) 517-523
130. Garzon M., Vaughan R.A., Uhl G.R., Kuhar M.J., and Pickel V.M. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J. Comp. Neurol. 26 (1999) 197-210
131. Geinisman Y. Structural synaptic modifications associated with hippocampal LTP and behavioral learning. Cereb. Cortex 10 (2000) 952-962
132. Geinisman Y., Morrell F., and de Toledo-Morrell L. Perforated synapses on double-headed dendritic spines: A possible structural substrate of synaptic plasticity. Brain Res. 20 1-2 (1989) 326-329
133. Georges F., and Aston-Jones G. Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J. Neurosci. 15 (2001) RC160
134. Georges F., and Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: A novel excitatory amino acid input to midbrain dopamine neurons. J. Neurosci. 15 (2002) 5173-5187
135. Gerber G.J., Sing J., and Wise R.A. Pimozide attenuates lever pressing for water reinforcement in rats. Pharmacol. Biochem. Behav. 14 (1981) 201-205
136. Geschwind D.H. Sharing gene expression data: An array of options. Nat. Rev. Neurosci. 2 (2001) 435-438
137. Gessa G.L., Muntoni F., Collu M., Vargiu L., and Mereu G. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 25 (1985) 201-203
138. Gessa G.L., Melis M., Muntoni A.L., and Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 2 (1998) 39-44
139. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., and Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci. 22 (2002) 1146-1154
140. Ginovart N., Farde L., Halldin C., and Swahn C.G. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Synapse 31 (1999) 154-162
141. Gobert A., Dekeyne A., and Millan M.J. The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572. Neuropharmacology 10 (2000) 1608-1616
142. Goeders N.E., and Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science 19 4612 (1983) 773-775
143. Goldberg S.R. Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J. Pharmacol. Exp. Ther. 186 (1973) 18-30
144. Goldberg S.R., Spealman R.D., and Goldberg D.M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 30 4520 (1981) 573-575
145. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24 (1988) 19-28
146. Gonon F.G., and Buda M.J. Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltametry in the rat striatum. Neuroscience 14 (1985) 765-774
147. Grace A.A., and Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons: 1. Identification and characterization. Neuroscience 10 (1983) 301-315
148. Grace A.A., and Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons: 2. Action potential generating mechanisms and morphological correlates. Neuroscience 10 (1983) 317-331
149. Grace A.A., and Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons: 3. Evidence for electrotonic coupling. Neuroscience 10 (1983) 333-348
150. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: Single spike firing. J. Neurosci. 4 (1984) 2866-2876
151. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: Burst firing. J. Neurosci. 4 (1984) 2877-2890
152. Grace A.A., and Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9 (1989) 3463-3481
153. Grasing K., Li N., He S., Parrish C., Delich J., and Glowa J. A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats. Psychopharmacology (Berlin) 168 (2003) 387-396
154. Grenhoff J., Aston-Jones G., and Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand. 128 (1986) 351-358
155. Grenhoff J., Tung C.S., and Svensson T.H. The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 134 (1988) 567-568
156. Grenhoff J., and Svensson T.H. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur. J. Pharmacol. 8 (1989) 11-18
157. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., and Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. 93 (1993) 11-25
158. Grenhoff J., North R.A., and Johnson S.W. Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur. J. Neurosci. 1 (1995) 1707-1713
159. Griffiths R., Bigelow G., and Liebson I. Effect of ethanol self-administration on choice behavior: Money vs. socializing. Pharmacol. Biochem. Behav. 3 (1975) 443-446
160. Grillner P., and Mercuri N.B. Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav. Brain Res. 10 1-2 (2002) 149-169
161. Groves P.M., Wilson C.J., Young S.J., and Rebec G.V. Self-inhibition by dopaminergic neurons. Science 7 4214 (1975) 522-528
162. Gysling K., and Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 24 (1983) 119-127
163. Guarraci F.A., and Kapp B.S. An electrophysiological characterization of ventral tegmental area dopaminergic neurons during differential pavlovian fear conditioning in the awake rabbit. Behav. Brain Res. 99 (1999) 169-179
164. Harrigan S.E., and Downs D.A. Self-administration of heroin, acetylmethadol, morphine, and methadone in rhesus monkeys. Life Sci. 22 (1978) 619-623
165. Harrison A.A., Liem Y.T., and Markou A. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25 (2001) 55-71
166. Hayashi M.L., Choi S.Y., Rao B.S., Jung H.Y., Lee H.K., Zhang D., Chattarji S., Kirkwood A., and Tonegawa S. Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice. Neuron 10 (2004) 773-787
167. Hayes R.J., and Gardner E.L. The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues. Eur. J. Neurosci. 20 (2004) 273-280
168. Hedou G., Feldon J., and Heidbreder C.A. Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferents to subterritories of the nucleus accumbens. Eur. J. Pharmacol. 14 (1999) 143-155
169. Hedou G., Homberg J., Feldon J., and Heidbreder C.A. Amphetamine microinfusion in the dorso-ventral axis of the prefrontal cortex differentially modulates dopamine neurotransmission in the shell-core subterritories of the nucleus accumbens. Ann. NY Acad. Sci. 29 (1999) 823-827
170. Heidbreder C., and Feldon J. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29 (1998) 310-322
171. Henneman E., Somjen G., and Carpenter D.O. Functional significance of cell size in spinal motoneurons. J. Neurophysiol. 28 (1965) 560-580
172. Henneman E., Somjen G., and Carpenter D.O. Excitability and inhibitability of motoneurons of different sizes. J. Neurophysiol. 28 (1965) 599-620
173. Herberg L.J., Montgomery A.M., and Rose I.C. Tolerance and sensitization to stimulant and depressant effects of nicotine in intracranial self-stimulation in the rat. Behav. Pharmacol. 4 (1993) 419-427
174. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 3 (1991) 267-274
175. Hernandez L., and Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by
176. Herve D., Pickel V.M., Joh T.H., and Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res. 1 1-2 (1987) 71-83
177. Hietala J., West C., Syvalahti E., Nagren K., Lehikoinen P., Sonninen P., and Ruotsalainen U. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berlin) 116 (1994) 285-290
178. Hildebrand B.E., Nomikos G.G., Hertel P., Schilstrom B., and Svensson T.H. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res. 1 1-2 (1998) 214-225
179. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., and Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology (Berlin) 81 (1983) 158-163
180. Hoebel B.G., Mark G.P., and West H.L. Conditioned release of neurotransmitters as measured by microdialysis. Clin. Neuropharmacol. 15 Suppl 1 Pt A (1992) 704A-705A
181. Hope B., Kosofsky B., Hyman S.E., and Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. USA 1 (1992) 5764-5768
182. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., and Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13 (1994) 1235-1244
183. Howell L.L., and Wilcox K.M. The dopamine transporter and cocaine medication development: Drug self-administration in nonhuman primates. J. Pharmacol. Exp. Ther. 298 (2001) 1-6
184. Hutcheson D.M., Everitt B.J., Robbins T.W., and Dickinson A. The role of withdrawal in heroin addiction: Enhances reward or promotes avoidance?. Nat. Neurosci. 4 (2001) 943-947
185. Hyman S.E., and Malenka R.C. Addiction and the brain: The neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 (2001) 695-703
186. Imperato A., and Di Chiara G. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: A new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4 (1984) 966-977
187. Ise Y., Narita M., Nagase H., and Suzuki T. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology (Berlin) 151 (2000) 49-54
188. Jentsch J.D., Taylor J.R., Elsworth J.D., Redmond Jr. D.E., and Roth R.H. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: Involvement in frontostriatal cognitive deficits. Neuroscience 90 (1999) 823-832
189. Jentsch J.D., Roth R.H., and Taylor J.R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: Implications for mental disorders and psychotropic drug action. Prog. Brain Res. 126 (2000) 433-453
190. Johanson C.E. Effects of intravenous cocaine, diethylpropion, d-amphetamine and perphenazine on responding maintained by food delivery and shock avoidance in rhesus monkeys. J. Pharmacol. Exp. Ther. 204 (1978) 118-129
191. Johnson S.W., Mercuri N.B., and North R.A. 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J. Neurosci. 12 (1992) 2000-2006
192. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosi. 12 (1992) 483-488
193. Johnson S.W., and North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 450 (1992) 455-468
194. Jones B.E., and Prada J.A. Relapse to morphine use in dog. Psychopharmacologia 30 (1973) 1-12
195. Jones S., and Kauer J.A. Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J. Neurosci. 15 (1999) 9780-9787
196. Jones S., Kornblum J.L., and Kauer J.A. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci. 1 (2000) 5575-5580
197. Justinova Z., Tanda G., Redhi G.H., and Goldberg S.R. Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berlin) 169 (2003) 135-140
198. Kakade S., and Dayan P. Dopamine: Generalization and bonuses. Neural Netw. 15 4-6 (2002) 549-559
199. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16 (1991) 223-244
200. Katz J.L. Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice. Psychopharmacology (Berlin) 98 (1989) 445-447
201. Kauer J.A. Learning mechanisms in addiction: Synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu. Rev. Physiol. 66 (2004) 447-475
202. Kelland M.D., Freeman A.S., Rubin J., and Chiodo L.A. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res. Bull. 31 (1993) 539-546
203. Kelz M.B., Chen J., Carlezon Jr. W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., and Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 16 6750 (1999) 272-276
204. Kenny P.J., Gasparini F., and Markou A. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA){plus 45 degree rule}kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J. Pharmacol. Exp. Ther. 306 (2003) 1068-1076
205. Khantzian E.J. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am. J. Psychiatry 142 (1985) 1259-1264
206. Kim J.A., Pollak K.A., Hjelmstad G.O., and Fields H.L. A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism. Proc. Natl. Acad. Sci. USA 13 (2004) 5664-5669
207. Kitai S.T., Shepard P.D., Callaway J.C., and Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr. Opin. Neurobiol. 9 (1999) 690-697
208. Kokkinidis L., and Zacharko R.M. Intracranial self-stimulation in mice using a modified hole-board task: Effects of d-amphetamine. Psychopharmacology (Berlin) 68 (1980) 169-171
209. Koob G.F. Neural mechanisms of drug reinforcement. Ann. NY Acad. Sci. 28 (1992) 171-191
210. Koob G.F. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
211. Koob G.F. Hedonic valence, dopamine and motivation. Mol. Psychiatry 1 (1996) 186-189
212. Kornetsky C., Esposito R.U., McLean S., and Jacobson J.O. Intracranial self-stimulation thresholds: A model for the hedonic effects of drugs of abuse. Arch. Gen. Psychiatry 36 (1979) 289-292
213. Krystal J.H., and Redmond Jr. D.E. A preliminary description of acute physical dependence on morphine in the vervet monkey. Pharmacol. Biochem. Behav. 18 (1983) 289-291
214. Lacey M.G. Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area. Prog. Brain Res. 99 (1993) 251-276
215. Lacey M.G., Mercuri N.B., and North R.A. On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. J. Physiol. 401 (1988) 437-453
216. Lacey M.G., Calabresi P., and North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J. Pharmacol. Exp. Ther. 253 (1990) 395-400
217. Lacey M.G., Mercuri N.B., and North R.A. Actions of cocaine on rat dopaminergic neurones in vitro. Br. J. Pharmacol. 99 (1990) 731-735
218. Lang W.J., Latiff A.A., Mcqueen A., and Singer G. Self administration of nicotine with and without a food delivery schedule. Pharmacol. Biochem. Behav. 7 (1977) 65-70
219. Lee T.H., and Ellinwood Jr. E.H. Time-dependent changes in the sensitivity of dopamine neurons to low doses of apomorphine following amphetamine infusion. Brain Res. 27 (1989) 17-29
220. Lee T.H., Gao W.Y., Davidson C., and Ellinwood E.H. Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase. Neuropsychopharmacology 21 (1999) 127-136
221. Lepore M., Vorel S.R., Lowinson J., and Gardner E.L. Conditioned place preference induced by delta 9-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward. Life Sci. 56 23-24 (1995) 2073-2080
222. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., and Porrino L.J. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 15 (2001) 2799-2807
223. Li Y., and Kauer J.A. Repeated exposure to amphetamine disrupts dopaminergic modulation of excitatory synaptic plasticity and neurotransmission in nucleus accumbens. Synapse 51 (2004) 1-10
224. Lin D., Koob G.F., and Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat: Interactions between the two drugs. Psychopharmacology (Berlin) 145 (1999) 283-294
225. Lindvall O., and Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. Suppl. 412 (1974) 1-48
226. Lingford-Hughes A., and Nutt D. Neurobiology of addiction and implications for treatment. Br. J. Psychiatry 182 (2003) 97-100
227. Lingford-Hughes A.R., Davies S.J., McIver S., Williams T.M., Daglish M.R., and Nutt D.J. Addiction. Br. Med. Bull. 65 (2003) 209-222
228. Liu Z.H., and Jin W.Q. Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats. Neuroreport 28 (2004) 1479-1481
229. Loughlin S.E., and Fallon J.H. Dopaminergic and non-dopaminergic projections to amygdala from substantia nigra and ventral tegmental area. Brain Res. 7 (1983) 334-338
230. Lu Q., Hutchins A.E., Doyle C.M., Lundblad J.R., and Kwok R.P. Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription. J. Biol. Chem. 2 (2003) 15727-15734
231. Lukas S.E., Moreton J.E., and Khazan N. Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat. Psychopharmacology (Berlin) 73 (1981) 12-16
232. Lukas S.E., Griffiths R.R., Bradford L.D., Brady J.V., and Daley L. A tethering system for intravenous and intragastric drug administration in the baboon. Pharmacol. Biochem. Behav. 17 (1982) 823-829
233. Lukas S.E., Griffiths R.R., Brady J.V., and Wurster R.M. Phencyclidine-analogue self-injection by the baboon. Psychopharmacology (Berlin) 83 (1984) 316-320
234. Luscher C., Nicoll R.A., Malenka R.C., and Muller D. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat. Neurosci. 3 (2000) 545-550
235. Lynch G., Muller D., Seubert P., and Larson J. Long-term potentiation: Persisting problems and recent results. Brain Res. Bull. 21 (1988) 363-372
236. Mackler S.A., and Eberwine J.H. The molecular biology of addictive drugs. Mol. Neurobiol. 5 (1991) 45-58
237. Malinow R., Mainen Z.F., and Hayashi Y. LTP mechanisms: From silence to four-lane traffic. Curr. Opin. Neurobiol. 10 (2000) 352-357
238. Mansvelder H.D., and McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27 (2000) 349-357
239. Mansvelder H.D., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 14 (2002) 905-919
240. Manzoni O.J., and Williams J.T. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 1 (1999) 6629-6636
241. Manzoni O., Pujalte D., Williams J., and Bockaert J. Decreased presynaptic sensitivity to adenosine after cocaine withdrawal. J. Neurosci. 1 (1998) 7996-8002
242. Marinelli M., Cooper D.C., Baker L.K., and White F.J. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology (Berlin) 168 1-2 (2003) 84-98
243. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
244. Markou A., and Koob G.F. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology 7 (1992) 213-224
245. Matthews R.T., and German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11 (1984) 617-625
246. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6 (2003) 1208-1215
247. McKetin R., and Mattick R.P. Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls. Drug Alcohol Depend. 1 (1998) 181-184
248. Meisch R.A. Oral drug self-administration: An overview of laboratory animal studies. Alcohol 24 (2001) 117-128
249. Meisch R.A., and Henningfield J.E. Drinking of ethanol by rhesus monkeys: Experimental strategies for establishing ethanol as a reinforcer. Adv. Exp. Med. Biol. 85B (1977) 443-463
250. Meisch R.A., and Lemaire G.A. Effects of feeding condition on orally delivered ethanol as a reinforcer for rhesus monkeys. Alcohol 8 (1991) 55-63
251. Meisch R.A., and Stewart R.B. Ethanol as a reinforcer: A review of laboratory studies of non-human primates. Behav. Pharmacol. 5 4 And 5 (1994) 425-440
252. Melis M., Gessa G.L., and Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 993-1006
253. Melis M., Camarini R., Ungless M.A., and Bonci A. Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J. Neurosci. 15 (2002) 2074-2082
254. Melis M., Perra S., Muntoni A.L., Pillola G., Lutz B., Morsicano G., Di Marzo V., Gessa G.L., and Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24 (2004) 10707-10715
255. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., and Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24 (2004) 53-62
256. Mello N.K., Negus S.S., Lukas S.E., Mendelson J.H., Sholar J.W., and Drieze J. A primate model of polydrug abuse: Cocaine and heroin combinations. J. Pharmacol. Exp. Ther. 274 (1995) 1325-1337
257. Meltzer L.T., Serpa K.A., and Christoffersen C.L. Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons. Synapse 26 (1997) 184-193
258. Mercuri N.B., Stratta F., Calabresi P., and Bernardi G. Electrophysiological evidence for the presence of ionotropic and metabotropic excitatory amino acid receptors on dopaminergic neurons of the rat mesencephalon: An in vitro study. Funct. Neurol. 7 (1992) 231-234
259. Mercuri N.B., Stratta F., Calabresi P., Bonci A., and Bernardi G. Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons. Neuroscience 56 (1993) 399-407
260. Mercuri N.B., Bonci A., Calabresi P., Stefani A., and Bernardi G. Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur. J. Neurosci. 1 (1995) 462-469
261. Mercuri N.B., Bonci A., Calabresi P., and Bernardi G. Characterization of a barium-sensitive outward current following glutamate application on rat midbrain dopaminergic cells. Eur. J. Neurosci. 8 (1996) 1780-1786
262. Mereu G., Yoon K.W., Boi V., Gessa G.L., Naes L., and Westfall T.C. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol. 23 (1987) 395-399
263. Mereu G., Costa E., Armstrong D.M., and Vicini S. Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci. 11 (1991) 1359-1366
264. Mirenowicz J., and Schultz W. Importance of unpredictability for reward responses in primate dopamine neurons. J. Neurophysiol. 72 (1994) 1024-1027
265. Moore R.J., Vinsant S.L., Nader M.A., Porrino L.J., and Friedman D.P. Effect of cocaine self-administration on striatal dopamine D1 receptors in rhesus monkeys. Synapse 28 (1998) 1-9
266. Moore R.J., Vinsant S.L., Nader M.A., Porrino L.J., and Friedman D.P. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30 (1998) 88-96
267. Moratalla R., Elibol B., Vallejo M., and Graybiel A.M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17 (1996) 147-156
268. Morse A.C., Schulteis G., Holloway F.A., and Koob G.F. Conditioned place aversion to the "hangover" phase of acute ethanol administration in the rat. Alcohol 22 (2000) 19-24
269. Mucha R.F. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res. 25 (1987) 214-220
270. Mucha R.F., and Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berlin) 86 (1985) 274-280
271. Mucha R.F., Gritti M.D., and Kim C. Aversive properties of opiate withdrawal studied in rats. NIDA. Res Monogr. 75 (1986) 567-570
272. Murphy N.P., Lam H.A., and Maidment N.T. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J. Neurochem. 79 (2001) 626-635
273. Murthy V.N., Schikorski T., Stevens C.F., and Zhu Y. Inactivity produces increases in neurotransmitter release and synapse size. Neuron 20 (2001) 673-682
274. Musto D.F. Historical perspectives. In: Lowinson J.H., Ruiz P., Millman R.B., and Langrod J.C. (Eds). "Substance Abuse: A Comprehensive Textbook". 3rd ed. (1997)
275. Nedergaard S., Flatman J.A., and Engberg I. Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J. Physiol. 466 (1993) 727-747
276. Nestler E.J. Under siege: The brain on opiates. Neuron 16 (1996) 897-900
277. Nestler E.J. Genes and addiction. Nat. Genet. 26 (2000) 277-281
278. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. 10 (2001) 201-217
279. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. Feb 2 (2001) 119-128 (published erratum in Nat. Rev. Neurosci. 2, 215)
280. Nestler E.J. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
281. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 3 5335 (1997) 58-63
282. Nestler E.J., Barrot M., and Self D.W. DeltaFosB: A sustained molecular switch for addiction. Proc. Natl. Acad. Sci. USA 25 (2001) 11042-11046
283. Neuhoff H., Neu A., Liss B., and Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J. Neurosci. 15 (2002) 1290-1302
284. Norrholm S.D., Bibb J.A., Nestler E.J., Ouimet C.C., Taylor J.R., and Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116 (2003) 19-22
285. Nye H.E., and Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49 (1996) 636-645
286. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. 434 (1987) 117-165
287. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., and Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J. Neurosci. 15 (1995) 5859-5869
288. O'Brien C.P. Drug Addiction and Drug Abuse. In: Hardman J., and Limbird L.E. (Eds). "Goodman and Gilman's. The Pharmacological Basis of Therapeutics". 10th ed. (2001), The McGraw-Hill Companies
289. O'Brien C.P., and Fishman M.W. Substance use disorders. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). "Neuropsychopharmacology: The Fifth Generation of Progress" (2002), Lippincott Williams and Wilkins
290. Olds J., and Minler P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47 (1954) 419-427
291. Overton P.G., and Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev. 25 (1997) 312-334
292. Paladini C.A., Iribe Y., and Tepper J.M. GABAA receptor stimulation blocks NMDA-induced bursting of dopaminergic neurons in vitro by decreasing input resistance. Brain Res. 19 1-2 (1999) 145-151 (published erratum in Brain Res. 18, 275).
293. Paladini C.A., Robinson S., Morikawa H., Williams J.T., and Palmiter R.D. Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc. Natl. Acad. Sci. USA 4 (2003) 2866-2871
294. Paladini C.A., and Williams J.T. Noradrenergic inhibition of midbrain dopamine neurons. J. Neurosci. 12 (2004) 4568-4575
295. Parsons L.H., Smith A.D., and Justice Jr. J.B. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9 (1991) 60-65
296. Paterson N.E., Myers C., and Markou A. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berlin) 152 (2000) 440-446
297. Pessia M., Jiang Z.G., North R.A., and Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 22 (1994) 324-330
298. Peters A., and Feldman M.L. The projection of the lateral geniculate nucleus to area 17 of the rat cerebral cortex. I. General description. J Neurocytol. 5 (1976) 63-84
299. Phillips A.G., and LePiane F.G. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol. Biochem. Behav. 12 (1980) 965-968
300. Phillips A.G., Mora F., and Rolls E.T. Intracerebral self-administration of amphetamine by rhesus monkeys. Neurosci. Lett. 12 (1981) 81-86
301. Phillips T. Animal models for the genetic study of human alcohol phenotypes. Alcohol Res. Health 26 (2002) 202-207
302. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., and Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 8 6663 (1998) 173-177
303. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., and Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science 3 5296 (1997) 83-86
304. Pickel V.M., and Sesack S.R. Electron microscopy of central dopamine systems. In: Bloom F.E., and Kupfer D.J. (Eds). "Neuropsychopharmacology. The Fourth Generation of Progress". 4th ed. (1997), Lippincott Williams & Wilkins, New York
305. Pickens R., and Harris W.C. Self-administration of d-amphetamine by rats. Psychopharmacologia 12 (1968) 158-163
306. Pickens R., and Thompson T. Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. J. Pharmacol. Exp. Ther. 161 (1968) 122-129
307. Pickens R., and Thompson T. Intravenous preparations for self-administration of drugs by animals. Am. Psychol. 30 (1975) 274-276
308. Pidoplichko V.I., DeBiasi M., Williams J.T., and Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 27 6658 (1997) 401-404
309. Pieper W.A. Induction of physical dependence upon alcohol in nonhuman primates. Adv. Exp. Med. Biol. 56 (1975) 327-337
310. Ping H.X., and Shepard P.D. Apamin-sensitive Ca(2+)-activated K+ channels regulate pacemaker activity in nigral dopamine neurons. Neuroreport 29 (1996) 809-804.
311. Ping H.X., and Shepard P.D. Blockade of SK-type Ca2+-activated K+ channels uncovers a Ca2+-dependent slow afterdepolarization in nigral dopamine neurons. J. Neurophysiol. 81 (1999) 977-984
312. Piomelli D. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4 (2003) 873-884
313. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 19 (1995) 12304-12308
314. Pothos E., Rada P., Mark G.P., and Hoebel B.G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 6 1-2 (1991) 348-350
315. Prisco S., Natoli S., Bernardi G., and Mercuri N.B. Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons. Neuropharmacology 42 (2002) 289-296
316. Pulvirenti L., and Diana M. Drug dependence as a disorder of neural plasticity: Focus on dopamine and glutamate. Rev. Neurosci. 12 (2001) 141-158
317. Quertemont E. Genetic polymorphism in ethanol metabolism: Acetaldehyde contribution to alcohol abuse and alcoholism. Mol. Psychiatry 9 (2004) 570-581
318. Rada P., Jensen K., and Hoebel B.G. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology (Berlin) 157 (2001) 105-110
319. Rada P.V., Mark G.P., Yeomans J.J., and Hoebel B.G. Acetylcholine release in ventral tegmental area by hypothalamic self-stimulation, eating, and drinking. Pharmacol. Biochem. Behav. 65 (2000) 375-379
320. Rasmussen K., and Czachura J.F. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons. Neuroreport 29 (1995) 329-332
321. Redmond Jr. D.E., and Huang Y.H. The primate locus coeruleus and effects of clonidine on opiate withdrawal. J. Clin. Psychiatry 43 6 Pt 2 (1982) 25-29
322. Reynolds J.N., and Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw. 15 4-6 (2002) 507-521
323. Reynolds J.N., Hyland B.I., and Wickens J.R. A cellular mechanism of reward-related learning. Nature 6 6851 (2001) 67-70
324. Richards C.D., Shiroyama T., and Kitai S.T. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat. Neuroscience 80 (1997) 545-557
325. Richardson N.R., and Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy. J. Neurosci. Methods 66 (1996) 1-11
326. Risner M.E. Intravenous self-administration of phencyclidine and related compounds in the dog. J. Pharmacol. Exp. Ther. 221 (1982) 637-644
327. Risner M.E., and Goldberg S.R. A comparison of nicotine and cocaine self-administration in the dog: Fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J. Pharmacol. Exp. Ther. 224 (1983) 319-326
328. Risner M.E., and Jones B.E. Self-administration of CNS stimulants by dog. Psychopharmacologia 17 (1975) 207-213
329. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 4 4819 (1987) 1219-1223
330. Robbins T.W., and Everitt B.J. Neurobehavioral mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6 (1996) 228-236
331. Robbins T.W., and Everitt B.J. Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem. 78 (2002) 625-636
332. Robertson M.W., Leslie C.A., and Bennett Jr. J.P. Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 11 (1991) 337-339
333. Robinson T.E., and Berridge K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18 (1993) 247-291
334. Robinson T.E., and Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 1 (1997) 8491-8497
335. Robinson T.E., and Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33 (1999) 160-162
336. Robinson T.E., and Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11 (1999) 1598-1604
337. Robinson T.E., Gorny G., Mitton E., and Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 1 (2001) 257-266
338. Rodd-Henricks Z.A., Melendez R.I., Zaffaroni A., Goldstein A., McBride W.J., and Li T.K. The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacol. Biochem. Behav. 72 1-2 (2002) 55-64
339. Rodd-Henricks Z.A., McKinzie D.L., Melendez R.I., Berry N., Murphy J.M., and McBride W.J. Effects of serotonin-3 receptor antagonists on the intracranial self-administration of ethanol within the ventral tegmental area of Wistar rats. Psychopharmacology (Berlin) 165 (2003) 252-259
340. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F., Sahakian B.J., and Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1999) 322-239
341. Romo R., and Schultz W. Dopamine neurons of the monkey midbrain: Contingencies of responses to active touch during self-initiated arm movements. J. Neurophysiol. 63 (1990) 592-606
342. Romo R., and Schultz W. Neuronal activity preceding self-initiated or externally timed arm movements in area 6 of monkey cortex. Exp. Brain Res. 67 (1987) 656-662
343. Rossetti Z.L., Hmaidan Y., and Gessa G.L. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 20 2-3 (1992) 227-234
344. Rossetti Z.L., Melis F., Carboni S., Diana M., and Gessa G.L. Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine. Alcohol Clin. Exp. Res. 16 (1992) 529-532
345. Salamone J.D., Cousins M.S., and Snyder B.J. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis. Neurosci. Biobehav. Rev. 21 (1997) 341-359
346. Sanudo-Pena M.C., Tsou K., Delay E.R., Hohman A.G., Force M., and Walker J.M. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci. Lett. 21 (1997) 125-128
347. Scannevin R.H., and Huganir R.L. Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1 (2000) 133-141
348. Schaefer G.J., and Michael R.P. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol. Biochem. Behav. 25 (1986) 1263-1269
349. Schiller J., Schiller Y., and Clapham D.E. NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation. Nat. Neurosci. 1 (1998) 114-118
350. Schilstrom B., Svensson H.M., Svensson T.H., and Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience 85 (1998) 1005-1009
351. Schlaepfer T.E., Pearlson G.D., Wong D.F., Marenco S., and Dannals R.F. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am. J. Psychiatry 154 (1997) 1209-1213
352. Schulteis G., Markou A., Cole M., and Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. USA 20 (1995) 5880-5884
353. Schulteis G., Markou A., Gold L.H., Stinus L., and Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271 (1994) 1391-1398
354. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-27
355. Schultz W. The phasic reward signal of primate dopamine neurons. Adv. Pharmacol. 42 (1998) 686-690
356. Schultz W. The reward signal of midbrain dopamine neurons. News Physiol. Sci. 14 (1999) 249-255
357. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 14 5306 (1997) 1593-1599
358. Schuster C.R., and Thompson T. Self administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9 (1969) 483-502
359. Schwartz R.D. Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labeled with [3H]acetylcholine in rat brain. Life Sci. 9 (1986) 2111-2119
360. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 639-677
361. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., and Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 1 (1998) 1848-1859
362. Semba K., and Fibiger H.C. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: A retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol. 15 (1992) 387-410
363. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 8 (1992) 145-160
364. Seutin V., Verbanck P., Massotte L., and Dresse A. Evidence for the presence of N-methyl-d-aspartate receptors in the ventral tegmental area of the rat: An electrophysiological in vitro study. Brain Res. 23 (1990) 147-150
365. Seutin V., Johnson S.W., and North R.A. Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res. 10 1-2 (1993) 341-344
366. Shaw-Lutchman T.Z., Barrot M., Wallace T., Gilden L., Zachariou V., Impey S., Duman R.S., Storm D., and Nestler E.J. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 1 (2002) 3663-3672
367. Shaw-Lutchman T.Z., Impey S., Storm D., and Nestler E.J. Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse 48 (2003) 10-17
368. Shen K.Z., and Johnson S.W. A slow excitatory postsynaptic current mediated by G-protein-coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur. J. Neurosci. 9 (1997) 48-54
369. Shen R.Y., and Chiodo L.A. Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area. Brain Res. 17 1-2 (1993) 289-293
370. Shepherd G.M. "Neurobiology,". 3rd ed. (1994), Oxford University Press
371. Shepherd G.M. The dendritic spine: A multifunctional integrative unit. J. Neurophysiol. 75 (1996) 2197-2210
372. Shi W.X., Pun C.L., Zhang X.X., Jones M.D., and Bunney B.S. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J. Neurosci. 1 (2000) 3504-3511
373. Shippenberg T.S., and Koob G.F. Recent advances in animal models of drug addiction. In: Davis K.I., Chaney D., Coyle J.T., and Nemeroff C. (Eds). "Neuropsychopharmacology. The Fifth Generation of Progress". 5th ed. (2002), Lippincott Williams & Wilkins, New York
374. Silva N.L., Pechura C.M., and Barker J.L. Postnatal rat nigrostriatal dopaminergic neurons exhibit five types of potassium conductances. J. Neurophysiol. 64 (1990) 262-272
375. Sklair-Tavron L., Shi W.X., Lane S.B., Harris H.W., Bunney B.S., and Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA 1 (1996) 11202-11207
376. Smith S.G., and Davis W.M. Intravenous alcohol self-administration in the rat. Pharmacol. Res. Commun. 6 (1974) 379-402
377. Smith Y., Charara A., and Parent A. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. J. Comp. Neurol. 8 (1996) 231-253
378. Somjen G., Carpenter D.O., and Henneman E. Responses of motoneurons of different sizes to graded stimulation of supraspinal centers of the brain. J. Neurophysiol. 28 (1965) 958-965
379. Sonders M.S., Zhu S.J., Zahniser N.R., Kavanaugh M.P., and Amara S.G. Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants. J. Neurosci. 1 (1997) 960-974
380. Spanagel R., and Weiss F. The dopamine hypothesis of reward: Past and current status. Trends Neurosci. 22 (1999) 521-527
381. Spealman R.D., and Goldberg S.R. Drug self-administration by laboratory animals: Control by schedules of reinforcement. Annu. Rev. Pharmacol. Toxicol. 18 (1978) 313-339
382. Spealman R.D., Madras B.K., and Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251 (1989) 142-149
383. Spiga S., Serra G.P., Puddu M.C., Foddai M., and Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur. J. Neurosci. 17 (2003) 605-612
384. Spiga S., Valdes B., Serra G.P., Puddu C.M., Collu S., Ennas M.G., Pisano M., and Diana M. Cannabinoid withdrawal-induced abnormalities in the VTA: Confocal laser scanning microscopy. 2003 Abstract Viewer{plus 45 degree rule}Itinerary Planner (2003), Society for Neuroscience, Washington, DC Program no. 110.16.
385. Stafford D., LeSage M.G., and Glowa J.R. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: A review. Psychopharmacology (Berlin) 139 (1998) 169-184
386. Steffensen S.C., Svingos A.L., Pickel V.M., and Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 1 (1998) 8003-8015
387. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol. Biochem. Behav. 20 (1984) 917-923
388. Stinus L., Le Moal M., and Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37 (1990) 767-773
389. Stretch R., and Gerber G.J. A method for chronic intravenous drug administration in squirrel monkeys. Can. J. Physiol. Pharmacol. 48 (1970) 575-781
390. Sugita S., Johnson S.W., and North R.A. Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci. Lett. 6 (1992) 207-211
391. Suzuki T., Kishimoto Y., and Misawa M. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci. 59 (1996) 1667-1674
392. Svensson T.H., and Tung C.S. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 136 (1989) 135-136
393. Szabo B., Wallmichrath I., Mathonia P., and Pfreundtner C. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97 (2000) 89-97
394. Taber M.T., Das S., and Fibiger H.C. Cortical regulation of subcortical dopamine release: Mediation via the ventral tegmental area. J Neurochem. 65 (1995) 1407-1410
395. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 27 5321 (1997) 2048-2050
396. Tanda G., Loddo P., and Di Chiara G. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur. J. Pharmacol. 2 1-2 (1999) 23-26
397. Tanda G., Munzar P., and Goldberg S.R. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3 (2000) 1073-1074
398. Tepper J.M., Martin L.P., and Anderson D.R. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15 (1995) 3092-3103
399. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 10 1-2 (1991) 100-110
400. Thierry A.M., Deniau J.M., Chevalier G., Ferron A., and Glowinski J. An electrophysiological analysis of some afferent and efferent pathways of the rat prefrontal cortex. Prog. Brain Res. 58 (1983) 257-261
401. Thompson T., and Schuster C.R. Morphine self-administration, food-reinforced, and avoidance behaviors in Rhesus monkeys. Psychopharmacologia 7 (1964) 87-94
402. Thompson T., and Pickens R. Stimulant self-administration by animals: Some comparisons with opiate self-administration. Fed Proc. 29 (1970) 6-12
403. Turkkan J.S., McCaul M.E., and Stitzer M.L. Psychophysiological effects of alcohol-related stimuli: II. Enhancement with alcohol availability. Alcohol Clin. Exp. Res. 13 (1989) 392-398
404. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
405. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. Suppl. 367 (1971) 1-48
406. Ungless M.A., Whistler J.L., Malenka R.C., and Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 31 6837 (2001) 583-587
407. Ungless M.A., Magill P.J., and Bolam J.P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 26 5666 (2004) 2040-2042
408. Valdez G.R., Sabino V., and Koob G.F. Increased anxiety-like behavior and ethanol self-administration in dependent rats: Reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin. Exp. Res. 28 (2004) 865-872
409. Valjent E., and Maldonado R.A. behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berlin) 147 (2000) 436-438
410. Van Bockstaele E.J., and Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 5 1-2 (1995) 215-221
411. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Hitzemann R., Ding Y.S., Pappas N., Shea C., and Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin. Exp. Res. 20 (1996) 1594-1598
412. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., and Shea K. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
413. Volkow N.D., Fowler J.S., and Wang G.J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J. Psychopharmacol. 13 (1999) 337-345
414. Volkow N.D., Wang G.J., Fowler J.S., Hitzemann R., Angrist B., Gatley S.J., Logan J., Ding Y.S., and Pappas N. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction. Am. J. Psychiatry 156 (1999) 19-26
415. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Wong C., Hitzemann R., and Pappas N.R. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J. Pharmacol. Exp. Ther. 291 (1999) 409-415
416. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol. Psychiatry 9 (2004) 557-569
417. Vrana S.L., Vrana K.E., Koves T.R., Smith J.E., and Dworkin S.I. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem. 61 (1993) 2262-2268
418. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J. Comp. Neurol. 8 (1989) 314-335
419. Waddington J.L., and Cross A.J. Neurochemical changes following kainic acid lesions of the nucleus accumbens: Implications for a GABAergic accumbal-ventral tegmental pathway. Life Sci. 22 (1978) 1011-1014
420. Wang G.J., Volkow N.D., Fowler J.S., Logan J., Abumrad N.N., Hitzemann R.J., Pappas N.S., and Pascani K. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16 (1997) 174-182
421. Wang T., and French E.D. L-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: Extra- and intracellular electrophysiological studies in brain slices. Brain Res. 12 (1993) 299-306
422. Wang T., and French E.D. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse 13 (1993) 270-277
423. Wang T., and French E.D. NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum. Brain Res. Bull. 36 (1995) 39-43
424. Watkins S.S., Stinus L., Koob G.F., and Markou A. Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects. J. Pharmacol. Exp. Ther. 292 (2000) 1053-1064
425. Weeks J.R. Experimental morphine addiction: Method for automatic intravenous injections in unrestrained rats. Science 12 (1962) 143-144
426. Weiss F., Markou A., Lorang M.T., and Koob G.F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 16 (1992) 314-318
427. Weiss F., Parsons L.H., Schulteis G., Hyytia P., Lorang M.T., Bloom F.E., and Koob G.F. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 15 (1996) 3474-3485
428. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., and Richter R.R. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. NY Acad. Sci. 937 (2001) 1-26
429. Wenger T., Moldrich G., and Furst S. Neuromorphological background of cannabis addiction. Brain Res. Bull. 15 (2003) 125-128
430. Westerink B.H. Brain microdialysis and its application for the study of animal behavior. Behav. Brain Res. 70 (1995) 103-124
431. Wightman R.M., and Robinson D.L. Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82 (2002) 721-735
432. Williams G.V., and Millar J. Concentration-dependent actions of stimulated dopamine release on neuronal activity in rat striatum. Neuroscience 39 (1990) 1-16
433. Williams H.P., Manderscheid P.Z., Schwartz M., and Frank R.A. Cocaine's effects on rate of intracranial self-stimulation. Pharmacol. Biochem. Behav. 40 (1991) 273-277
434. Wilson C.J., Groves P.M., Kitai S.T., and Linder J.C. Three-dimensional structure of dendritic spines in the rat neostriatum. J. Neurosci. 3 (1983) 383-388
435. Winger G.D., and Woods J.H. The reinforcing property of ethanol in the rhesus monkey. I. Initiation, maintenance and termination of intravenous ethanol-reinforced responding. Ann. NY Acad. Sci. 30 (1973) 162-165
436. Wise R.A. Neuroleptic attenuation of intracranial self-stimulation: Reward or performance deficits?. Life Sci. 22 (1978) 535-542
437. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
438. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6 (1996) 243-251
439. Wise R.A., and Bozarth M.A. Action of drugs of abuse on brain reward systems: An update with specific attention to opiates. Pharmacol. Biochem. Behav. 17 (1982) 239-243
440. Wise R.A., and Munn E. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology (Berlin) 117 (1995) 130-136
441. Wise R.A., Spindler J., and Legault L. Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can. J. Psychol. 32 (1978) 77-85
442. Wise R.A., Spindler J., deWit H., and Gerberg G.J. Neuroleptic-induced "anhedonia" in rats: Pimozide blocks reward quality of food. Science 21 4352 (1978) 262-264
443. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37 (1991) 475-524
444. Woolverton W.L., and Kleven M.S. Evidence for cocaine dependence in monkeys following a prolonged period of exposure. Psychopharmacology (Berlin) 94 (1988) 288-291
445. Wu X., and French E.D. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: An electrophysiological assessment. Neuropharmacology 28 (2000) 391-408
446. Yeomans J.S. Two substrates for medial forebrain bundle self-stimulation: Myelinated axons and dopamine axons. Neurosci. Biobehav. Rev. 13 2-3 (1989) 91-98
447. Yeomans J.S., Mathur A., and Tampakeras M. Rewarding brain stimulation: Role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci. 107 (1993) 1077-1087
448. Yeomans J.S., Takeuchi J., Baptista M., Flynn D.D., Lepik K., Nobrega J., Fulton J., and Ralph M.R. Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells. J. Neurosci. 1 (2000) 8861-8867
449. Yeomans J., Forster G., and Blaha C. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci. 27 22-23 (2001) 2449-2456
450. Yin R., and French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: An in vitro electrophysiological study. Brain Res. Bull. 51 (2000) 507-514
451. Yokel R.A., and Pickens R. Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J. Pharmacol. Exp. Ther. 187 (1973) 27-33
452. Yokel R.A., and Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 14 4176 (1975) 547-549
453. Yokel R.A., and Wise R.A. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berlin) 17 (1976) 311-318
454. Young A.M., and Woods J.H. Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J. Pharmacol. Exp. Ther. 218 (1981) 720-727
455. Zetterstrom T., Sharp T., Marsden C.A., and Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: Changes after d-amphetamine. J. Neurochem. 41 (1983) 1769-1773
456. Zheng F., and Johnson S.W. Group I metabotropic glutamate receptor-mediated enhancement of dopamine cell burst firing in rat ventral tegmental area in vitro. Brain Res. 6 1-2 (2002) 171-174
457. Zocchi A., Orsini C., Cabib S., and Puglisi-Allegra S. Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: An in vivo study in mice. Neuroscience 82 (1998) 521-528
458. Zocchi A., Girlanda E., Varnier G., Sartori I., Zanetti L., Wildish G.A., Lennon M., Mugnaini M., and Heidbreder C.A. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse. Synapse 15 (2003) 293-302
459. Zoli M., and Agnati L.F. Wiring and volume transmission in the central nervous system: The concept of closed and open synapses. Prog. Neurobiol. 49 (1996) 363-380